In terms of tumor somatic mutations, this study rigorously observed that the overall mutation rate in the high-risk group (95.05%) was higher than that in the low-risk group (92.18%), and TP53 was the most frequently mutated gene in both groups. The gene discussed is TP53; the disease is neoplasm.